Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03144661
Title An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Incyte Corporation
Indications

nasopharynx carcinoma

cholangiocarcinoma

esophageal cancer

hepatocellular carcinoma

ovarian serous carcinoma

Advanced Solid Tumor

Therapies

INCB062079

Age Groups: senior | adult
Covered Countries USA | BEL

Facility Status City State Zip Country Details
University of Alabama Birmingham Alabama 35294 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of Toledo Medical Center Toledo Ohio 43614 United States Details
Institut Jules Bordet Brussels 1000 Belgium Details
Cliniques Universitaires Saint-Luc Brussels 1200 Belgium Details
University Hospital (UZ) Leuven Leuven 3000 Belgium Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field